ACLX Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Arcellx Inc - Alpha Spread
A

Arcellx Inc
NASDAQ:ACLX

Watchlist Manager
Arcellx Inc
NASDAQ:ACLX
Watchlist
Price: 86.61 USD 1.38% Market Closed
Market Cap: 4.6B USD
Have any thoughts about
Arcellx Inc?
Write Note

Wall Street
Price Targets

ACLX Price Targets Summary
Arcellx Inc

Wall Street analysts forecast ACLX stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACLX is 81.46 USD with a low forecast of 70.7 USD and a high forecast of 91.35 USD.

Lowest
Price Target
70.7 USD
18% Downside
Average
Price Target
81.46 USD
6% Downside
Highest
Price Target
91.35 USD
5% Upside

ACLX Last Price Targets
Arcellx Inc

The latest public price target was made on May 31, 2024 by Biren Amin from Piper Sandler , who expects ACLX stock to drop by 19% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Biren Amin
Piper Sandler
70 USD
Downside 19%
3 months ago
May 31, 2024
Arcellx initiated with an Overweight at Piper Sandler
TheFly
Benjamin Burnett
Stifel Nicolaus
83 USD
Downside 4%
4 months ago
May 15, 2024
Arcellx price target raised to $83 from $82 at Stifel
TheFly
Cory Kasimov
Evercore ISI
85 USD
Downside 2%
4 months ago
May 13, 2024
Evercore ISI Starts Arcellx Inc. (ACLX) at Outperform
StreetInsider
Gil Blum
Needham
81 USD
Downside 6%
6 months ago
Mar 18, 2024
Arcellx Inc. (ACLX) PT Raised to $81 at Needham
StreetInsider
Biren Amin
Piper Sandler
Price Target 70 USD
Upside/Downside 19%
View Source
Benjamin Burnett
Stifel Nicolaus
Price Target 83 USD
Upside/Downside 4%
View Source
Cory Kasimov
Evercore ISI
Price Target 85 USD
Upside/Downside 2%
View Source
Gil Blum
Needham
Price Target 81 USD
Upside/Downside 6%
View Source
Arcellx Inc Competitors:
Price Targets
006280
Green Cross Corp
2% Downside
TWST
Twist Bioscience Corp
17% Upside
AMGN
Amgen Inc
1% Downside
BBIO
BridgeBio Pharma Inc
88% Upside
ZYME
Zymeworks Inc
13% Upside
603087
Gan & Lee Pharmaceuticals
80% Upside
688363
Bloomage Biotechnology Corp Ltd
47% Upside
1952
Everest Medicines Ltd
18% Upside

Revenue
Forecast

Revenue Estimate
Arcellx Inc

The compound annual growth rate of Arcellx Inc's revenue for the next 3 years is 9%.

N/A
Past Growth
9%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Arcellx Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Arcellx Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-48%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACLX's stock price target?
Price Target
81.46 USD

According to Wall Street analysts, the average 1-year price target for ACLX is 81.46 USD with a low forecast of 70.7 USD and a high forecast of 91.35 USD.

What is Arcellx Inc's Revenue forecast?
Projected CAGR
9%

The compound annual growth rate of Arcellx Inc's revenue for the next 3 years is 9%.

Back to Top